Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT00963105 · COMPLETED
Trial details
- NCT number
- NCT00963105
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-19
- Primary completion
- 2017-09-05
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.